Clinical trial
Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand
NCT00291499 · IBSA Institut Biochimique SA, Industry · Completed
Key facts
| NCT number | NCT00291499 |
|---|---|
| Title | Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand |
| Official title | Clinical Evaluation of Condrosulf 800 mg in the Treatment of Symptomatic OA of the Hand: a 6-month, Double-blind, Placebo Controlled Study |
| Lead sponsor | IBSA Institut Biochimique SA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthrosis |
| Intervention type | Drug, Other |
| Interventions | Chondroitin 4&6 sulfate (Condrosulf), Placebo |
| Enrollment | 163 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Feb 14, 2006 |
| Last update posted | Mar 4, 2021 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: